Ocugen, Inc.
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function…
Biotechnology
US, Malvern [HQ]
Strategy & Leadership
Mergers & Acquisitions Beta
M&As
M&A Deals · Breakdown
Ocugen, Inc. has no acquisition track records yet.
M&A Deals · History
Ocugen, Inc. has no acquisition track records yet.